TriSalus Life Sciences, Inc.
TLSI
$5.22
$0.000.00%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 11.29M | 16.48M | 3.97M | 11.78M | 21.38M |
| Total Receivables | 4.91M | 4.71M | 4.28M | 3.55M | 3.05M |
| Inventory | 4.00M | 3.44M | 2.91M | 2.55M | 1.63M |
| Prepaid Expenses | 3.61M | 3.31M | 2.03M | 2.99M | 2.98M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 23.81M | 27.94M | 13.19M | 20.86M | 29.04M |
|
|
|||||
| Total Current Assets | 23.81M | 27.94M | 13.19M | 20.86M | 29.04M |
| Net Property, Plant & Equipment | 3.25M | 2.95M | 3.16M | 3.27M | 3.15M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | 1.11M | 1.11M | 1.13M | 997.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 424.00K | 424.00K | 424.00K | 466.00K | 367.00K |
| Total Assets | 27.48M | 32.43M | 17.89M | 25.73M | 33.55M |
|
|
|||||
| Total Accounts Payable | 1.45M | 1.98M | 2.35M | 3.39M | 1.90M |
| Total Accrued Expenses | 7.84M | 9.37M | 11.39M | 10.53M | 6.60M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 266.00K | 323.00K | 363.00K | 351.00K | 379.00K |
| Total Finance Division Other Current Liabilities | 363.00K | 328.00K | 294.00K | 420.00K | 427.00K |
| Total Other Current Liabilities | 363.00K | 328.00K | 294.00K | 420.00K | 427.00K |
| Total Current Liabilities | 9.92M | 12.00M | 14.39M | 14.69M | 9.31M |
|
|
|||||
| Total Current Liabilities | 9.92M | 12.00M | 14.39M | 14.69M | 9.31M |
| Long-Term Debt | 21.68M | 21.29M | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.51M | 1.15M | 1.22M | 1.24M | 1.32M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 14.81M | 22.14M | 37.20M | 35.73M | 14.44M |
| Total Liabilities | 47.91M | 56.58M | 52.81M | 51.66M | 25.07M |
|
|
|||||
| Common Stock & APIC | 249.01M | 241.78M | 226.67M | 222.44M | 221.35M |
| Retained Earnings | -269.44M | -265.93M | -261.60M | -248.38M | -212.87M |
| Treasury Stock & Other | -- | -- | -- | -- | 1.00K |
| Total Common Equity | -20.43M | -24.15M | -34.92M | -25.94M | 8.49M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | 1.00K |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | 1.00K |
|
|
|||||
| Total Common Equity | -20.43M | -24.15M | -34.92M | -25.94M | 8.49M |
| Total Preferred Equity | -- | -- | -- | -- | 1.00K |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -20.43M | -24.15M | -34.92M | -25.94M | 8.49M |
|
|
|||||
